Liquid chromatography-tandem mass spectrometric assay for the non-nucleoside reverse transcriptase inhibitor rilpivirine in human plasma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liquid chromatography-tandem mass spectrometric assay for the non-nucleoside reverse transcriptase inhibitor rilpivirine in human plasma

Published:2012-06-22 Issue:2 Volume:27 Page:172-178
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomed. Chromatogr.

Author:

Burugula Laxminarayana¹,Pilli Nageswara Rao¹,Makula Ajitha¹,Lodagala Durga Srinivas²,Kandhagatla Rajnarayana³

Affiliation:

1. University College of Pharmaceutical Sciences; Jawaharlal Nehru Technological University; Kukatpally; Hyderabad; 500085; India

2. Bristl Laboratories Ltd; Laporte way, Luton; Bedfordshire; LU4 8WL; UK

3. Glukem Pharmaceuticals Pvt. Ltd; Cherlapally; Hyderabad; 500051; India

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference10 articles.

1. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society - USA Panel;Carpenter;Journal of the American Medical Association,1997

2. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial;Cohen;Lancet,2011

3. Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds;Else;Journal of Chromatography B,2010

4. FDA Label for rilpivirine tablets 2011 www.accessdata.fda.gov/drugsatfda_docs/label/2011/202022s000lbl.pdf

5. Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings;Ford;HIV/AIDS - Research and Palliative Care,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Method Development and Validation of Assay of Rilpivirine in Rilpivirine Tablets by RP-HPLC;International Journal of Innovative Science and Research Technology (IJISRT);2024-09-10

2. Analysis of Forced Degradation Products in Rilpivirine using RP-HPLC and Peak Purity Evaluation;Oriental Journal Of Chemistry;2023-12-27

3. A New stability indicating RP-UFLC method for the estimation of Rilpivirine in pharmaceutical dosage forms;Research Journal of Pharmacy and Technology;2023-07-24

4. Simultaneous quantification of (E) and (Z) isomers of rilpivirine and four degradation products in bulk and tablets by reversed‐phase ultra‐high‐performance liquid chromatography and confirmation of all by molecular weight;Journal of Separation Science;2023-04-14

5. Tandem mass spectrometry of small-molecule antiviral drugs: 1. HIV-related antivirals;International Journal of Mass Spectrometry;2020-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3